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a b s t r a c t
Cortex neuromodulation is promising approach for treatment of some neurological condi-
tions, especially neuropathic pain and Parkinson's disease. Effects of non-invasive cortical
stimulation are short lived; transcranial direct current stimulation (tDCS) and transcranial
alternating current stimulation (tACS) may be useful to assess the suitability for invasive
cortical stimulation. Direct cortical stimulation (DCS) is the method able to provide long-
lasting effects in treatment of neuropathic pain and some symptoms of Parkinson's disease
through the use of totally implantable systems that ensure a chronic stimulation.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http://www.elsevier.com/locate/pjnns1. Introduction
Cortical neuromodulation aims to induce stimulation of the
deﬁned cortical areas in attempt to reduce chronic symp-
toms of neurological diseases by directly altering brain
activity.
There are currently a number of standard invasive and
noninvasive cortical neuromodulation methods: some have
shown great promise in treating neurological disorders, while
other are already accepted in clinical practice. We illustrate
these methods by discussing results, advantages and dis-
advantages, and possible mechanisms of action.* Corresponding author at: Unit of Neurosurgery Department of Medic
Catanzaro, Italy.
E-mail address: lavano@unicz.it (A. Lavano).
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Direct electrical stimulation of precentral cortex (DCS), also
known as motor cortex stimulation (MCS), is an invasive
neuromodulation method in which paddle lead is implanted
in the epidural space or more rarely in subdural space over the
motor cortex to deliver chronic electrical stimulation. Lead
placement is carried out through a craniotomy or burr holes
performed respectively under general and local anesthesia
with sedation [35]. The stimulation waveform is a continuous
biphasic pulse train delivered at an amplitude below motor
threshold.al and Surgical Sciences, UMG of Catanzaro, Viale Europa, 88100
eurological Society.
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subdural intracranial bleeding depending on the implantation
site and infection. Seizures induction has been reported
following DCS programming and during chronic stimulation,
not necessary leading to the development of epilepsy [24].
Chronic direct stimulation of the precentral cortex is a
clinically accepted treatment for medication refractory neu-
ropathic pain [1,2,34,36].
This method was ﬁrst reported by Tsubokawa in 1991 [32]
for the treatment of central pain; by the time its indications
have been extended to various types of peripheral and central
deafferentation pain refractory to common treatments in-
cluded, when indicated, spinal cord stimulation (post-stroke
pain, phantom limb pain, spinal cord injury pain, postherpetic
neuralgia and trigeminal neuropathic pain).
DCS has proven effective in intractable chronic pain
conditions but no randomized controlled study has yet been
published. A literature review by the European Federation of
Neurological Societies covering more than 200 patients treated
with DCS found that 50–60% of patients had signiﬁcant pain
relief [3]. Others scientiﬁc studies conﬁrm that different forms
of central pain and peripheral neuropathic pain can be
effectively treated with DCS [37,39]. Review of the literature
reports that patients with neuropathic facial pain achieved ≥
60% pain relief with DCS. Post-stroke pain responds nearly as
well, with almost two-thirds of patients obtaining good to
excellent relief [24,27,36].
The mechanisms underlying the effects on neuropathic
pain is actually still unknown. A corticospinal system
relatively intact is necessary, but not sufﬁcient, to achieve
pain control, while success in DCS treatment does not require
intact somatosensory system. It has been proposed that action
mechanism may act by reinforcing the control of non-
nociceptive sensory inputs on nociceptive systems at the
level of the thalamus, dorsal column nuclei and spinal cord but
other suggested mechanism involves supraspinal structures
(cingulate gyrus, orbitofrontal cortex and brainstem)
[4,10,11,28,29]. DCS-induced pain relief is associated with an
improved sensory discrimination within the painful zone
suggesting that stimulation of motor cortex acts on somato-
sensory pathways and sensory processing [24].
Reported amplitudes range from 0.5 V to 10 V, rates from
5 Hz to 130 Hz and pulse widths from 60 ms to 450 ms,
increasing the intensity by 20% if necessary [5,6,23,30,37,39].
DCS of the precentral cortex is also used to treat Parkinson's
disease (PD) and essential tremor (ET) [4–6,8–10,28–31]. The
number of patients treated remains small but Direct Cortical
Stimulation can reduce PD symptoms (tremor, rigidity,
akinesia, freezing of gait, balance) and to a greater extent
axial symptoms. One reason that DCS is not more widely used
as treatment for PD is that, as with chronic pain, not all
patients show signiﬁcant symptom improvement. Further-
more DCS is not yet as effective as deep brain stimulation (DBS)
for PD. Nevertheless, some authors [10,11,29] concluded that
DCS is a important treatment option for a subgroup of PD
patients who are contraindicated for DBS. DCS has also been
used in a small number of patients to treat medically
refractory tinnitus and depression with some success [12].
There are several mechanisms proposed to explain the
effects of DCS on PD. The motor cortex region is the ﬁnalcommon link between deeper circuitry coordinating move-
ment and the spinal cord itself. It is one of the few areas in
which the pyramidal and extrapyramidal systems interact.
The motor cortex is connected to the basal ganglia indirectly
via a cortico-striatal pathway and directly via a cortico-
subthalamic circuit. DCS may exert its effect modulating the
subthalamic nucleus (STN) directly or through the loop cortex-
striatum-lateral globus pallidus-STN [4]. Chronic stimulation
of motor cortex may alter not only the ﬁring patterns in the
basal ganglia but also, due to its location, the interactions
between the pyramidal and extrapyramidal systems [12].
Finally it may modulate the activity of the supplementary
motor area (SMA) or the ‘‘suppressor cortical system’’ [11].
In summary DCS can treat effectively neuropathic pain and
PD symptoms in some patients that are refractory to
pharmacological treatment and cannot be treated with other
stimulation techniques. However, it is difﬁcult to predict
which patients will respond. Since the method involves a
neurosurgical procedure, this has impact on its clinical
application.
3. Noninvasive cortical stimulation
Transcranial magnetic stimulation (TMS) is a noninvasive
neuromodulation method that uses a magnetic ﬁeld to induce
current ﬂow in the cortex by means of a ﬁgure-of-eight coil.
The stimulation waveform can be single, paired, or burst
pulses [4,7] usually applied repetitively (rTMS) and can be
delivered at amplitudes high enough to cause limb movement
when the coil is positioned over the motor cortex [33]. Two
rTMS procedures are used: low-frequency rTMS (1 Hz with
continuous trains of single pulses) and high-frequency rTMS
(more than 5 Hz with bursts of pulses).
Because it is noninvasive, TMS has a widely used in
research. TMS of the motor cortex has been explored as a
treatment for both neuropathic pain and PD [13,14]. While
signiﬁcant effects have been reported for treating both
disorders, they are often too modest to be clinically relevant
[15,16] or the effects tend to be short lived [3,17]. This
highlights one of the limitations of TMS: the strong magnetic
ﬁeld and stimulator size mean that it can only be used in
laboratory or clinical setting and cannot deliver chronic
stimulation.
Transcranial direct current stimulation (tDCS) and tran-
scranial alternating current stimulation (tACS) are noninva-
sive neuromodulation methods in which two large square
electrodes are placed on the scalp to deliver low amplitude
currents (typically <2 mA) that are able to cross the skull by
inducing effects on excitability of cortical neurons [18–20].
Main adverse effect of tDCS and tACS is the onset of burns on
the scalp at the site of the stimulating electrodes.
While TMS and DCS work by using high amplitude and
pulsed waveforms to initiate action potentials in axons [21],
the mechanisms behind tDCS and tACS are quite different and
are not completely understood. tDCS uses low amplitude
direct current to cause somatic and dendritic polarization
across a spatially broad neuronal population and has effects
that persist after stimulation has stopped [18,22]. tACS uses
low amplitude sine waves (alternating current) which also act
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 7 5 – 7 8 77on the soma and dendrite to cause small but signiﬁcant
changes in the membrane potential [19,23]. tACS can entrain
and synchronize ﬁring patterns across a population of neurons
[25,26]. Both tDCS and tACS show great promise in treating a
range of brain disorders. Firstly, in relation to PD tACS has
shown the most promising results; and secondly it is difﬁcult
to safely deliver direct current through implanted electrodes.
Brown's group in Oxford have shown the tACS can reduce
tremor by an average of 50% in PD patients when applied with
a closed-loop system [38]. Although only performed in a small
number of patients, the study was groundbreaking indicating
that tACS can greatly reduce one of the symptoms of PD. The
effect of tACS on the full range of PD symptoms has not yet
been assessed. The main drawback of using tACS to reduce
tremor is that once the electrode is removed the tremor
returns. It is not practical to chronically attach a stimulating
electrode to the scalp.
4. Conclusions
Cortex neuromodulation is very promising approach to
treating symptoms of a variety of neurological diseases. Even
if the effects of non-invasive cortical stimulation were to prove
to be short lived, tDCS and tACS may be useful to assess the
suitability of a given patient for more invasive cortical
stimulation. DCS is the only cortical neuromodulatory method
that can provide long-lasting effects in treatment of neuro-
pathic pain and some symptoms of Parkinson's disease
through the use of totally implantable systems that ensure
a chronic stimulation. However, further studies are needed to
evaluate and compare the effectiveness of the different types
of motor cortex stimulation even in comparison to DBS.
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